Pharmaceutical composition for treating hepatitis B and cirrhosis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and drug technology, applied in the direction of drug combination, digestive system, pharmaceutical formula, etc., to achieve the effects of rapidly reducing liver function serum enzymes, inhibiting virus replication, and reducing liver fibrosis
Inactive Publication Date: 2011-07-06
江兴利
View PDF4 Cites 5 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
At present, there is no specific drug
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0024] The preparation of embodiment 1 pharmaceutical composition pill of the present invention
[0025] Take 8g golden buckwheat, 5g black nightshade, 5g zedoary, 3g horsetail, 5g malan, 3g carrageenan, 5g fennel, 4g sophora flavescens, 4g capillary, 8g coix seed, 3g comfrey, after crushing, add appropriate auxiliary materials, Pan pills.
Embodiment 2
[0026] The preparation of embodiment 2 pharmaceutical composition decoction of the present invention
[0027] Take 8g golden buckwheat, 3g black nightshade, 2g zedoary, 2g horsetail, 3g malan, 3g carrageenan, 3g fennel, 3g flavescens, 3g capillary, 3g coix seed, 3g comfrey, add water and fry, combine the filtrate, Get decoction of the present invention.
Embodiment 3
[0028] Embodiment 3 Preparation of pharmaceutical composition formula granules of the present invention
[0029] Take 4g golden buckwheat, 5g black nightshade, 5g zedoary, 3g horsetail, 5g malan, 5g carrageenan, 5g fennel, 5g flavescens, 5g capillary, 8g coix seed, 5g comfrey, after crushing, add appropriate auxiliary materials, Pan pills. After respectively adding water for extraction, the filtrate is concentrated, and auxiliary materials are added to prepare formula granules respectively, thus obtaining the formula granules of the present invention. Mix before use.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a pharmaceutical composition for treating hepatopathy, which is a preparation prepared by the following active pharmaceutical ingredients in portions by weight: 3-5 portions of black nightshade herb, 2-3 portions of common scouring rush herb, 4-8 portions of wild buckwheat rhizome, 3-5 portions of Indian kalimeris herb, 2-5 portions of zedoary, 3-5 portions of carrageen, 3-5 portions of Indian rorippa herb, 3-5 portions of lightyellow sophora root, 3-5 portions of virgate wormwood herb, 3-8 portions of coix seed and 3-5 portions of sinkiang arnebia root. The pharmaceutical composition can effectively inhibit virus replication, convert hepatitis B e-antigen and hepatitis B virus (DNA: deoxyribonucleic acid) gene polymerase to be negative within 40 weeks, effectively treat hepatitis B, further reduce the liver fibrosis level, improve the organic disorder in liver and spleen, increase the seralbumin, quickly reduce the liver functional seroenzyme, restore liver functions, have a good effect of protecting the liver, and effectively treat viral hepatitis and cirrhosis; and the pharmaceutical composition particularly has significant treatment effect for the hepatitis B and the cirrhosis after various types of the hepatitis.
Description
technical field [0001] The invention relates to a pharmaceutical composition for treating hepatitis B and liver cirrhosis. It belongs to the field of medicine. Background technique [0002] The liver is the largest digestive gland in the human digestive system and an important organ for human metabolism. However, with the increasingly serious environmental pollution, poor eating habits and other factors, the incidence of liver diseases has increased significantly. Currently, common liver diseases include viral hepatitis, liver cancer, fatty liver, alcoholic liver, and cirrhosis. [0003] Hepatitis B is one of the common viral hepatitis. It can be transmitted through blood, mother to child, damaged skin and sexual contact. It is also a common chronic infectious disease. According to the report of the World Health Organization (WHO), chronic hepatitis B accounts for the seventh among the top ten causes of death in the world, and 30% of hepatitis B patients will eventually d...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more